Table 2.
Educational material | Description/purpose |
---|---|
Healthcare professional educational brochure | Describe the role of the prescriber in the Erivedge®▼ pregnancy prevention programme |
Healthcare professional reminder card | Contained a summary of pregnancy prevention measures and contact information for healthcare professionals to report suspected adverse drug reactions to the Company |
Verification of Counselling Form | Confirmation checklist for prescriber and patient after the prescriber had educated the patient on the teratogenic risk of Erivedge®▼ |
Summary of product characteristics | Teratogenicity of Erivedge®▼ incorporated under section ‘4.4 Special warnings and precautions for use’; also highlighted that the Company provided educational materials for the pregnancy prevention programme for awareness |